The short answer
Antacids containing calcium carbonate can interfere with oral phenytoin and should not be taken at the same time. A pharmacist should confirm the schedule for your exact product. A universal two-to-three-hour rule for every calcium supplement is not established.
What this answer covers
Oral calcium products with oral phenytoin; antacid salts, nutritional preparations and intravenous treatment differ.
- Supplement or preparation
- Calcium
- Medication ingredient
- phenytoin
The warning concerns particular antacids
The phenytoin label names calcium carbonate and magnesium hydroxide among antacids that can lower drug levels. This is an administration issue for oral treatment; it should not be generalized automatically to every mineral salt or a medicine given intravenously.
Small studies had different results
One crossover study found reduced exposure with certain antacids, while a two-person study using other preparations found no absorption change. These differences make product and schedule important; the studies do not establish a uniform effect for all supplements.
Use an antacid-specific schedule
The American Epilepsy Society advises taking antacids at least two hours after phenytoin. That is professional guidance for antacids, not proof that two or three hours is protective for every mineral supplement. Ask your pharmacist to apply it to the actual products.
Do not change the seizure medicine yourself
Keep the prescribed phenytoin formulation and dosing schedule. Starting, stopping or changing a product that affects absorption may call for medication-level checks. New seizures or suspected adverse effects need clinical assessment, not an extra dose taken to compensate.
Evidence and practical considerations
Absorption & effectiveness
Antacids containing calcium carbonate can interfere with oral phenytoin and should not be taken at the same time. A pharmacist should confirm the schedule for your exact product. A universal two-to-three-hour rule for every calcium supplement is not established.
- Exact scope
- Oral calcium products with oral phenytoin; antacid salts, nutritional preparations and intravenous treatment differ. with Oral phenytoin; free-acid and sodium-salt formulations are explicitly distinguished.
- Medication form and route
- oral
What remains uncertain
- No universal risk rate or dose interval is established. Specific original-source limitations and access status are documented.
Factors that may matter: Exact preparation and amount; Medication formulation and drug levels; Seizure history and other treatments.
Read the supporting source summaries
Source 1: Current U.S. regulatory labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral phenytoin for supported seizure indications.
Labels name folic acid and St John’s wort as possible causes of lower phenytoin levels. Calcium-carbonate and magnesium-hydroxide antacids should not be taken simultaneously. Abrupt withdrawal can worsen seizures.
How this applies: Exact medication precautions with the formulation bridge explicitly retained.
A generic mineral is not every antacid salt. Free-acid and sodium formulations have different drug content; oral absorption findings do not apply to intravenous administration.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight volunteers in a randomized crossover.
Calcium carbonate and aluminum-magnesium hydroxide reduced average exposure; another mixture’s reduction was not significant.
How this applies: Supports avoiding simultaneous specified antacids; preparation and schedule matter.
Large within-person and between-person variation. Intensive antacid schedule, not every nutritional salt or a trial proving a two-to-three-hour interval.
Source 3: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Two healthy volunteers.
No change in absorption rate or extent under the tested conditions.
How this applies: Contrary evidence prevents generalizing a fixed effect to all calcium and magnesium products.
Extremely small sample; differs from the larger antacid study in preparations and administration.
Source 4: Professional society clinical guidance
aesnet.org · Source check Sep 10, 2026
Population: People with epilepsy considering antacids.
Recommends taking the antacid at least two hours after phenytoin.
How this applies: Provides a practical antacid-specific instruction for a pharmacist to apply to the exact product.
Clinical guidance is not a validated universal interval for every supplement or every phenytoin formulation.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft with exact formulation limits, contrary evidence and source-access details. Clinical review not recorded. | |
| Research summary published |
Article revision: 01b0770644b052e4
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.